Abbott Appeals $1.9B Hit In Patent Suit Over Humira
Abbott Laboratories is appealing a $1.85 billion judgment imposed against it after a jury found that the drugmaker's arthritis treatment Humira infringed a patent asserted by Johnson & Johnson unit Centocor...To view the full article, register now.
Already a subscriber? Click here to view full article